Lidia Fonseca, Pfizer's chief digital and technology officer, discusses how the company leveraged AI and AWS to treat 1.3 billion patients globally in 2022. Pfizer centralized data, built AI capabilities, and migrated to the cloud, saving millions annually. The company created a Scientific Data Cloud with AWS, enabling faster research and drug development. Pfizer also implemented generative AI solutions using Amazon SageMaker and Bedrock to accelerate research and improve manufacturing efficiency. The partnership with AWS was crucial in Pfizer's rapid development and distribution of the COVID-19 vaccine, reducing the typical 8-10 year process to just 269 days. Fonseca highlights how digital technologies and AI continue to drive innovation across Pfizer's operations, from R&D to manufacturing and supply chain management.